Korean J Dermatol.
2011 Jan;49(1):45-49.
Cronkhite-Canada Syndrome That Developed in a Patient Taking Levothyroxine Sodium after Total Thyroidectomy
- Affiliations
-
- 1Department of Dermatology, The Catholic University of Korea College of Medicine, Seoul, Korea. tykimder@catholic.ac.kr
Abstract
- Cronkhite-Canada Syndrome (CCS) is a rare, non-inherited hamartomatous polyposis syndrome. It is characterized by diffuse gastrointestinal polyposis, diarrhea, weight loss and unique ectodermal manifestations such as alopecia, onychodystrophy and cutaneous hyperpigmentation. The etiology of CCS remains unknown, but an autoimmue contribution to the pathogenesis has been postulated. We report here on a 79-year-old male who has been diagnosed with CCS. He had been taking levothyroxine sodium after total thyroidectomy. To the best of our knowledge, this is the first case report of CCS in association with hypothyroidism and supplementation with levothyroxine sodium in the Korean medical literature.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Cronkhite-Canada Syndrome
- Polyposis of gastrointestinal tract after COVID-19 mRNA vaccination: a report of two cases
- A Case of Cronkhite-Canada Syndrome with Esophageal Candidiasis
- A Case of Massive Levothyroxine Intoxication in a Patient with Total Thyroidectomy
- Two Cases of Cronkhite - Canada Syndrome with Remission
